Skip to main content
. 2008 Jun;24(6):797–804. doi: 10.1089/aid.2007.0246

Table 2.

Resistance-Associated Mutations by Gene Location and Study Visit for Plasma Specimens

 
Patients with RAMs, n (%)
Resistance-associated mutation Enrollment (N = 55) 6–12 weeks (N = 97)
Reverse transcriptase
 M184V 1 (1.8) 5 (5.2)
 M41L 1 (1.8) 2 (2.1)
 D67N 0 1 (1.0)
 K70R 2 (3.6) 5 (5.2)
 L210W 1 (1.8) 0
 K219Q 0 1 (1.0)
 V75I 0 0
 K103N 1 (1.8) 3 (3.1)
 V118I 2 (3.6) 1 (1.0)
 G190A 0 0
 E44D 1 (1.8) 0
 V118I 1 (1.8) 0
 V179D 0 2 (2.1)
Protease
 D30N 1 (1.8) 1 (1.0)
 L33F 0 0
 M46I 2 (3.6) 1 (1.0)
 V82A 0 1 (1.0)